Response to treatment can vary widely among patients, highlighting the importance of personalized medicine. Certain patterns, such as the presence of specific biomarkers, can predict how well a patient will respond to targeted therapies. Advances in genomic sequencing have allowed for more precise treatment plans tailored to the individual’s genetic makeup, improving the effectiveness of cancer therapies.
